Tech Company Financing Transactions

Parthenon Therapeutics Funding Round

Northpond Ventures, Pfizer Venture Investments and Taiho Ventures invested in a $65 million Series A funding round for Parthenon Therapeutics. The financing round was announced by the company on 11/6/2021.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

1 Bdwy.
Cambridge, MA 02142
USA

Phone

Undisclosed

Website

www.parthenontx.com

Email Address

Not Recorded

Overview

We are scientists, drug developers, clinicians, pathologists, bioinformaticians, engineers, innovators, and cancer warriors redefining the treatment landscape for patients with recalcitrant cancers.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Laurent Audoly

        

Chief Marketing Officer

Guy Clifton

        

Chief Operating Officer

Olga Granaturova

        

Co-Founder

Glenn Begley

        

Browse more venture capital transactions:

Prev: 11/6/2021: Gro Biosciences venture capital transaction
Next: 11/6/2021: Clade Therapeutics venture capital transaction

Share this article

News on VC Transactions

We do our best to report on every notable VC transaction. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary